Key result
Intracoronary prourokinase restores TIMI 3 flow in a patient with dual coronary embolization after failed tirofiban.
Why the study?
Coronary embolism is gaining increasing recognition as an important factor contributing to acute myocardial infarction beyond atherosclerotic plaque rupture or erosion.
Case Report (n=1)
Intracoronary thrombolysis with prourokinase may be an effective rescue strategy for coronary embolization when standard PCI and glycoprotein IIb/IIIa inhibitors fail.
May expand options in refractory embolization; leaves open efficacy and safety in prospective trials.
Background: Thrombotic occlusion of the coronary artery, which succeeds the atherosclerotic plaquerupture or erosion, gives rise to a major portion of acute myocardial infarction (AMI) incidences.Nevertheless, coronary embolism is gaining increasing recognition as another important factor contributingto AMI. Case presentation: A 72-year-old woman with atrial fibrillation (AF) and diabetes mellitus histories,presented with chest pain radiating to the left arm and shoulder that began 6 hours prior to admission.Electrocardiogram revealed AF plus ST-segment elevation in the anterior leads.Intervention: Patient was first treated with anti-platelet agents (aspirin plus ticagrelor) and atorvastatin.Emergency coronary angiography depicted multi-site coronary embolization of the left circumflex artery(LCX) and the left anterior descending artery (LAD). Blood flow was not restored after intracoronaryinjection of 600 ug tirofiban. 40 mg recombinant human prourokinase was then administered via aspirationthrombectomy catheter. Outcome: Two weeks later, coronary angiography showed no residual obstructive lesion in the LCX andLAD with TIMI (thrombolysis in myocardial infarction) 3 flow. Conclusion: Primary percutaneous coronary intervention is the most effective measure. In the case offailed blood flow restoration, thrombolytic treatment in both intravenous and intracoronary route should beconsidered.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2021) conducted a case report in Dual coronary embolization associated with atrial fibrillation (n=1). Intracoronary recombinant human prourokinase via aspiration thrombectomy catheter was evaluated on Restoration of coronary blood flow. Intracoronary administration of 40 mg recombinant human prourokinase successfully restored TIMI 3 flow in a patient with dual coronary embolization after failed tirofiban treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: